Improving Aspirin Use in Diabetes: A Cluster Randomized Trial
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Our aim is to determine if a patient-directed intervention is more effective than computerized clinician reminders alone for improving aspirin use in adults with diabetes.
| Condition | Intervention |
|---|---|
|
Diabetes Mellitus |
Behavioral: Electronic prompt plus patient-directed intervention Behavioral: Electronic prompt to clinician to prescribe aspirin |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Improving Appropriate Aspirin Use Among Adults With Diabetes in a Primary Care Setting: Using an Electronic Medical Record to Target a Physician-supervised Nurse Practitioner Intervention |
- Patient reported aspirin use daily or every other day.
| Estimated Enrollment: | 300 |
| Study Start Date: | September 2004 |
| Estimated Study Completion Date: | May 2005 |
Many patients with diabetes do not use aspirin to prevent cardiovascular events. Quality improvement initiatives involving both patients and physicians may be more effective than physician-directed approaches alone.
In a large urban primary care internal medicine practice, this study seeks to test if a patient-directed intervention is more effective than computerized clinician reminders alone for improving the appropriate use of aspirin in adults with diabetes.
The study design is a cluster-randomized trial by physician. The frequency of self-reported regular aspirin use will be compared between patients cared for by physicians in the computerized reminder alone group and the computerized reminder plus physician-supervised, nurse practitioner intervention group.
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Diabetes mellitus
- Age at least 40 years old
- At least 2 clinic visits in the 18 months prior to the intervention
Exclusion Criteria:
- Primary care physician declined enrollment
Contacts and Locations| United States, Illinois | |
| Northwestern University, Division of General Internal Medicine | |
| Chicago, Illinois, United States, 60611 | |
| Principal Investigator: | Stephen D Persell, MD, MPH | Northwestern University |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00262977 History of Changes |
| Other Study ID Numbers: | 1402-001 |
| Study First Received: | December 5, 2005 |
| Last Updated: | July 21, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Northwestern University:
|
diabetes mellitus cardiovascular diseases aspirin quality of healthcare |
Additional relevant MeSH terms:
|
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Aspirin Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions Anti-Inflammatory Agents |
Therapeutic Uses Antirheumatic Agents Fibrinolytic Agents Fibrin Modulating Agents Molecular Mechanisms of Pharmacological Action Cardiovascular Agents Hematologic Agents Platelet Aggregation Inhibitors Cyclooxygenase Inhibitors Enzyme Inhibitors Antipyretics Central Nervous System Agents |
ClinicalTrials.gov processed this record on May 16, 2013